| Dr William Francis Kivett, MD, FAAD, FACS | |
|
1140 Sonoma Ave Ste 1a, Santa Rosa, CA 95405-4817 | |
| (707) 275-6410 | |
| Not Available |
| Full Name | Dr William Francis Kivett |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 49 Years |
| Location | 1140 Sonoma Ave Ste 1a, Santa Rosa, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235175902 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | G34668 (California) | Secondary |
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | G34668 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| California Pacific Medical Ctr-davies Campus Hosp | San francisco, CA | Hospital |
| Entity Name | Sutter Bay Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013950807 PECOS PAC ID: 4284538778 Enrollment ID: O20031125000909 |
News Archive
"PATH and OneWorld Health (OWH) on Friday announced that OWH will become an affiliate of PATH, bringing its drug development expertise and experience in neglected infectious diseases to bear on PATH's mission of improving global health through innovation," according to a PATH press release.
Derma Sciences, Inc., a specialty medical device/pharmaceutical company focused on advanced wound care, today announced that it would implement an 8-for-1 reverse split of its issued and outstanding common shares, effective for shareholders of record on February 1, 2010, and a proportional reduction of its authorized common and preferred shares.
Incyte Corporation announced this morning that INCB18424 (also referred to as INCB018424), its selective, orally available janus kinase (JAK) inhibitor, will be the subject of three oral presentations at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans.
s the COVID-19 pandemic continues to spread, researchers are turning their attention to the virus' biology, mechanism of action, and possible treatments. One of the targets are a group of immune cells called "neutrophils", which have been reported to infiltrate the respiratory tract of patients who have died from COVID-19.
Researchers at University of California San Diego School of Medicine and Arizona State University have received funding from The Michael J. Fox Foundation for Parkinson's Research to launch a multi-year, $1.7-million effort to identify blood-based biomarkers of Parkinson's disease, which could improve care and accelerate new treatments for the neurodegenerative disorder, which affects nearly 1 million Americans, with 60,000 new cases diagnosed annually.
› Verified 2 days ago
| Entity Name | Adventist Health Clearlake Hospital Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124018031 PECOS PAC ID: 3072421197 Enrollment ID: O20041112000573 |
News Archive
"PATH and OneWorld Health (OWH) on Friday announced that OWH will become an affiliate of PATH, bringing its drug development expertise and experience in neglected infectious diseases to bear on PATH's mission of improving global health through innovation," according to a PATH press release.
Derma Sciences, Inc., a specialty medical device/pharmaceutical company focused on advanced wound care, today announced that it would implement an 8-for-1 reverse split of its issued and outstanding common shares, effective for shareholders of record on February 1, 2010, and a proportional reduction of its authorized common and preferred shares.
Incyte Corporation announced this morning that INCB18424 (also referred to as INCB018424), its selective, orally available janus kinase (JAK) inhibitor, will be the subject of three oral presentations at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans.
s the COVID-19 pandemic continues to spread, researchers are turning their attention to the virus' biology, mechanism of action, and possible treatments. One of the targets are a group of immune cells called "neutrophils", which have been reported to infiltrate the respiratory tract of patients who have died from COVID-19.
Researchers at University of California San Diego School of Medicine and Arizona State University have received funding from The Michael J. Fox Foundation for Parkinson's Research to launch a multi-year, $1.7-million effort to identify blood-based biomarkers of Parkinson's disease, which could improve care and accelerate new treatments for the neurodegenerative disorder, which affects nearly 1 million Americans, with 60,000 new cases diagnosed annually.
› Verified 2 days ago
| Entity Name | Skin And Beauty Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073751129 PECOS PAC ID: 8628170347 Enrollment ID: O20070227000738 |
News Archive
"PATH and OneWorld Health (OWH) on Friday announced that OWH will become an affiliate of PATH, bringing its drug development expertise and experience in neglected infectious diseases to bear on PATH's mission of improving global health through innovation," according to a PATH press release.
Derma Sciences, Inc., a specialty medical device/pharmaceutical company focused on advanced wound care, today announced that it would implement an 8-for-1 reverse split of its issued and outstanding common shares, effective for shareholders of record on February 1, 2010, and a proportional reduction of its authorized common and preferred shares.
Incyte Corporation announced this morning that INCB18424 (also referred to as INCB018424), its selective, orally available janus kinase (JAK) inhibitor, will be the subject of three oral presentations at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans.
s the COVID-19 pandemic continues to spread, researchers are turning their attention to the virus' biology, mechanism of action, and possible treatments. One of the targets are a group of immune cells called "neutrophils", which have been reported to infiltrate the respiratory tract of patients who have died from COVID-19.
Researchers at University of California San Diego School of Medicine and Arizona State University have received funding from The Michael J. Fox Foundation for Parkinson's Research to launch a multi-year, $1.7-million effort to identify blood-based biomarkers of Parkinson's disease, which could improve care and accelerate new treatments for the neurodegenerative disorder, which affects nearly 1 million Americans, with 60,000 new cases diagnosed annually.
› Verified 2 days ago
| Entity Name | Csi Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871909804 PECOS PAC ID: 5890916845 Enrollment ID: O20141016001930 |
News Archive
"PATH and OneWorld Health (OWH) on Friday announced that OWH will become an affiliate of PATH, bringing its drug development expertise and experience in neglected infectious diseases to bear on PATH's mission of improving global health through innovation," according to a PATH press release.
Derma Sciences, Inc., a specialty medical device/pharmaceutical company focused on advanced wound care, today announced that it would implement an 8-for-1 reverse split of its issued and outstanding common shares, effective for shareholders of record on February 1, 2010, and a proportional reduction of its authorized common and preferred shares.
Incyte Corporation announced this morning that INCB18424 (also referred to as INCB018424), its selective, orally available janus kinase (JAK) inhibitor, will be the subject of three oral presentations at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans.
s the COVID-19 pandemic continues to spread, researchers are turning their attention to the virus' biology, mechanism of action, and possible treatments. One of the targets are a group of immune cells called "neutrophils", which have been reported to infiltrate the respiratory tract of patients who have died from COVID-19.
Researchers at University of California San Diego School of Medicine and Arizona State University have received funding from The Michael J. Fox Foundation for Parkinson's Research to launch a multi-year, $1.7-million effort to identify blood-based biomarkers of Parkinson's disease, which could improve care and accelerate new treatments for the neurodegenerative disorder, which affects nearly 1 million Americans, with 60,000 new cases diagnosed annually.
› Verified 2 days ago
| Entity Name | William F Kivett Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164024394 PECOS PAC ID: 0840604815 Enrollment ID: O20210202003348 |
News Archive
"PATH and OneWorld Health (OWH) on Friday announced that OWH will become an affiliate of PATH, bringing its drug development expertise and experience in neglected infectious diseases to bear on PATH's mission of improving global health through innovation," according to a PATH press release.
Derma Sciences, Inc., a specialty medical device/pharmaceutical company focused on advanced wound care, today announced that it would implement an 8-for-1 reverse split of its issued and outstanding common shares, effective for shareholders of record on February 1, 2010, and a proportional reduction of its authorized common and preferred shares.
Incyte Corporation announced this morning that INCB18424 (also referred to as INCB018424), its selective, orally available janus kinase (JAK) inhibitor, will be the subject of three oral presentations at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans.
s the COVID-19 pandemic continues to spread, researchers are turning their attention to the virus' biology, mechanism of action, and possible treatments. One of the targets are a group of immune cells called "neutrophils", which have been reported to infiltrate the respiratory tract of patients who have died from COVID-19.
Researchers at University of California San Diego School of Medicine and Arizona State University have received funding from The Michael J. Fox Foundation for Parkinson's Research to launch a multi-year, $1.7-million effort to identify blood-based biomarkers of Parkinson's disease, which could improve care and accelerate new treatments for the neurodegenerative disorder, which affects nearly 1 million Americans, with 60,000 new cases diagnosed annually.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Francis Kivett, MD, FAAD, FACS Po Box 2196, Windsor, CA 95492-2196 Ph: (707) 275-6410 | Dr William Francis Kivett, MD, FAAD, FACS 1140 Sonoma Ave Ste 1a, Santa Rosa, CA 95405-4817 Ph: (707) 275-6410 |
News Archive
"PATH and OneWorld Health (OWH) on Friday announced that OWH will become an affiliate of PATH, bringing its drug development expertise and experience in neglected infectious diseases to bear on PATH's mission of improving global health through innovation," according to a PATH press release.
Derma Sciences, Inc., a specialty medical device/pharmaceutical company focused on advanced wound care, today announced that it would implement an 8-for-1 reverse split of its issued and outstanding common shares, effective for shareholders of record on February 1, 2010, and a proportional reduction of its authorized common and preferred shares.
Incyte Corporation announced this morning that INCB18424 (also referred to as INCB018424), its selective, orally available janus kinase (JAK) inhibitor, will be the subject of three oral presentations at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans.
s the COVID-19 pandemic continues to spread, researchers are turning their attention to the virus' biology, mechanism of action, and possible treatments. One of the targets are a group of immune cells called "neutrophils", which have been reported to infiltrate the respiratory tract of patients who have died from COVID-19.
Researchers at University of California San Diego School of Medicine and Arizona State University have received funding from The Michael J. Fox Foundation for Parkinson's Research to launch a multi-year, $1.7-million effort to identify blood-based biomarkers of Parkinson's disease, which could improve care and accelerate new treatments for the neurodegenerative disorder, which affects nearly 1 million Americans, with 60,000 new cases diagnosed annually.
› Verified 2 days ago
Dr. Sabrina Ann Kidd, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 30 Mark West Springs Rd, Santa Rosa, CA 95403 Phone: 707-576-4000 | |
George M. Huang, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 401 Bicentennial Way, Santa Rosa, CA 95403 Phone: 707-571-4000 | |
Lucinda Romero, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 401 Bicentennial Way, Santa Rosa, CA 95403 Phone: 707-571-4000 | |
Elizabeth A Peralta, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3883 Airway Drive, Suite 201, Santa Rosa, CA 95403 Phone: 707-521-8900 Fax: 707-523-1309 | |
Brian Frederick Schmidt, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1701 4th St, Ste 200, Santa Rosa, CA 95404 Phone: 707-579-2100 Fax: 707-523-0616 | |
Brett J Schulte, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 121 Sotoyome St Ste 201, Santa Rosa, CA 95405 Phone: 707-579-2100 Fax: 707-523-0616 | |
Keith Forrest Korver, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3510 Unocal Pl Ste 207, Santa Rosa, CA 95403 Phone: 707-569-7860 Fax: 707-545-5408 |